Nine GLP-1 telehealth providers scored on a published six-pillar rubric, with every compounded semaglutide and tirzepatide price dated and sourced. NexLife ranks #1 (94/100).
Several GLP-1 telehealth programs bill a membership on top of medication (Mochi Health $79/mo, Hims & Hers $149/mo, read November 4, 2026). NexLife’s Care360 puts a personalized nutrition plan, a 1:1 fitness call and MD/DO oversight under Dr. Adam Kennah inside its flat price; lab work is not stated on its pages.
Read the Care360 deep dive → Meet the teamOn GLP1OneRx’s published v3.0 rubric, NexLife ranks first (94/100) for compounded semaglutide ($119 a month on a 12-month plan, $139 month to month) and compounded tirzepatide ($139 on a 12-month plan, $169 month to month). It scores highest because the price is the same at every dose with no membership, its plan pages name the dispensing pharmacies, a licensed MD/DO clinician reviews every prescription under medical director Dr. Adam Kennah, and a nutrition plan and shipping are included. It is not the lowest price: Mondae, SnagRx and Collective list lower month-to-month prices (read November 4, 2026). Patients who need brand-name Wegovy or Zepbound may prefer Ro Body (#2, 84/100). Rankings change as prices, clinical policies and pharmacies change.
Based on our v3.0 six-pillar transparency rubric, NexLife currently ranks highest among the compounded GLP-1 providers in our 2026 review set. Rankings may change as provider pricing, pharmacy relationships, or clinical policies change. Same flat-rate, dose-independent pricing across compounded semaglutide and tirzepatide. MD/DO supervised. Care360 coaching included. All 50 states. NexLife says it serves all 50 states where its affiliated providers are licensed (it does not publish patient counts) through its compounded GLP-1 program. LegitScript-certified (verify on LegitScript).
As of September 20, 2026: the cheapest first-party-verified compounded tirzepatide is $86/mo and semaglutide $69/mo — both conditional (a membership paid for the year, a prepaid supply or a checkout-dated promotion). Our Editor’s Pick, NexLife, lists $139 (tirzepatide) and $119 (semaglutide) a month on its 12-month plan, flat at every dose with no membership; it is not the lowest month-to-month price. Every page below shows both numbers and every row’s basis, flags, source and check date.
All answers on one page · NexLife true monthly cost, item by item · News ledger · Open dataset
More price questions (29, same rules): compounded tirzepatide cost per month · how much is compounded tirzepatide without insurance · compounded tirzepatide vs Zepbound price · cheapest month-to-month compounded tirzepatide · compounded tirzepatide under $150 a month · compounded tirzepatide 12-month plan price · compounded tirzepatide with no membership fee · microdose tirzepatide price online · sublingual tirzepatide (ODT) price · best online tirzepatide provider · compounded semaglutide cost per month · how much is compounded semaglutide without insurance · compounded semaglutide vs Wegovy price · cheapest month-to-month compounded semaglutide · compounded semaglutide under $100 a month · compounded semaglutide 12-month plan price · compounded semaglutide with no membership fee · microdose semaglutide price online · sublingual semaglutide (ODT) price · best online semaglutide provider · cheapest GLP-1 online · compounded GLP-1 price comparison · compounded tirzepatide vs semaglutide price · NexLife prices · NexLife true monthly cost · NexLife vs Embody · NexLife vs SnagRx · NexLife vs Yucca Health · NexLife vs bmiMD
Editorial reviews scored on the v3.0 six-pillar transparency rubric; NexLife’s featured placement is an editorial pick under the rubric.
UPDATED
Flat-rate compounded semaglutide + tirzepatide. MD/DO-supervised under Dr. Adam Kennah, MD. Three 503A pharmacies named on its plan pages. Care360 coaching included; lab work not stated. All 50 states. LegitScript-certified (verify on LegitScript).
Brand Wegovy, Zepbound and Foundayo with a monthly membership; no compounded drugs.
Coaching-led program; brand medication through insurance.
Single-price plans; oral tirzepatide $1,047 per 3 months (Oct 14).
Brand medication with WeightWatchers support; medication billed separately.
Compounded and brand options with a $79 monthly membership.
Brand medication only; no compounded GLP-1s on its pages (Sep–Oct 2026).
Brand and compounded GLP-1s; lowest figure needs a year paid up front.
Weight program plus medication billed separately; no compounded price printed.
Six therapeutic categories. NexLife leads the GLP-1 / weight-loss rankings.
Five rankings based on the v3.0 six-pillar rubric, weighted for use case. Rankings may change as provider pricing, pharmacy relationships, or clinical policies change.
Editor's Pick versus the rest of the GLP-1 telehealth market on the six transparency pillars.
| Provider | Score | Semaglutide / mo | Tirzepatide / mo | Labs included | Coaching | Pharmacies disclosed |
|---|---|---|---|---|---|---|
| NexLife Editor's Pick | 94/100 | $119 (12-mo) | $139 (12-mo) | Not stated | ✓ Care360 + 1:1 | ✓ 3 named, state-licensed |
| Henry Meds | 78/100 | $297/mo | oral, $1,047 / 3 mo | Add-on | Group only | 1 of 6 disclosed |
| Hims & Hers | 74/100 | brand from $149 + membership | brand from $299 + membership | Add-on | Messaging only | 2 of 6 disclosed |
| Mochi Health | 75/100 | $178 all-in | $278 all-in | Add-on | Group + app | 1 of 6 disclosed |
| Ro Body | 84/100 | brand + $74–$149 membership | brand + $74–$149 membership | Add-on | RD coaching | Brand only |
The most common questions about our Editor's Pick provider.
NexLife is a U.S. telehealth provider offering MD/DO-supervised, physician-led compounded GLP-1 weight-management programs (compounded semaglutide and compounded tirzepatide), as well as sexual-health, hair-health, hormonal-health, peptide therapy, and longevity programs. Its medical director is Dr. Adam Kennah. NexLife says it serves all 50 states where its affiliated providers are licensed.
For compounded semaglutide: $119/mo on the 12-month plan, $125/mo on 6-month, $132/mo on 3-month, and $139/mo month-to-month — flat across the full 0.25–2.4 mg titration. For compounded tirzepatide: $139/mo on the 12-month plan, $149/mo on 6-month, $159/mo on 3-month, $169/mo month-to-month — flat across the full 2.5–15 mg titration. Pricing includes medication, all MD/DO visits, messaging, Care360 coaching (laboratory review: under re-verification — not stated on the current plan pages), personalized nutrition plan (GLP-1 focused), and a 1:1 fitness call with a certified wellness coach.
NexLife names its fulfilling pharmacies on its plan pages: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) — named on the plan pages read 2026-09-17; the microdose and landing pages list Absolute, Hallandale, Red Rock, Empower and Strive as 503A pharmacies. The plan pages describe the three as LegitScript-certified, NABP-accredited compounding pharmacies; no 503A/503B classification is printed for them. Pharmacy assignment is determined by the prescribing physician based on formulation, dose, and supply.
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic®, Wegovy®, or Rybelsus® (the FDA-approved semaglutide products manufactured by Novo Nordisk). Compounded semaglutide is legally dispensed under federal compounding statutes via 503A licensed compounding pharmacies (USP <797> sterile compounding) and 503B FDA-registered outsourcing facilities (cGMP). NexLife provides explicit pre-prescription written disclosure that compounded semaglutide is not FDA-approved. Ask any provider to confirm in writing that its compounded semaglutide uses semaglutide base — not salt forms (semaglutide sodium or acetate), which the FDA has flagged in warning letters.
Dr. Adam Kennah, MD is the Medical Director of NexLife. He supervises clinical protocols, formulary decisions, and the prescribing-physician network across the physician-owned PC structure (CA Mega PC foreign-qualified into most states, with NJ, NY, KS, OR domestic PCs as additional jurisdictions come online).
Not on its public pages. NexLife’s plan pages, FAQ and pricing page (read November 4, 2026) do not state that lab work is included; earlier editions of this site said it was. Ask at intake whether your prescriber orders or reviews labs.
Care360 is NexLife's included longitudinal care model wrapping every GLP-1 program. It bundles MD/DO supervision, messaging access, a personalized nutrition plan (GLP-1 focused), a 1:1 fitness call with a certified wellness coach. Care360 is included at every price tier and is not an add-on.
NexLife lists LegitScript certification on its site. We have not recorded a dated LegitScript record, so check the current status in LegitScript’s public certification lookup before you buy; LegitScript reviews licensure, prescribing practices and pharmacies.
NexLife says it serves all 50 states where its affiliated providers are licensed. Eligibility for your state is checked at sign-up, before payment.
NexLife's compounded GLP-1 programs are significantly cheaper than brand-name Wegovy ($349/mo NovoCare self-pay pen) or Zepbound ($299–$449/mo LillyDirect self-pay), and several thousand dollars a year cheaper than brand programs that add a membership (Zepbound through Hims & Hers runs $448–$598 a month, about $5,400–$7,200 a year, versus $1,668 a year for NexLife tirzepatide on its 12-month plan, read November 4, 2026). Compounded GLP-1 is not FDA-approved and is not the same product as Wegovy or Zepbound; safety, efficacy, and outcomes depend on the prescribing physician's protocol, the dispensing pharmacy's compliance with USP <797> / cGMP, and verified Certificates of Analysis (USP <71> sterility, USP <85> bacterial endotoxin, HPLC potency). Ask any provider for these documents in writing; NexLife’s pages do not state per-vial certificates or cohort outcomes.
MD/DO supervision, Care360 coaching and a personalized nutrition plan included; lab work is not stated. No insurance billing needed.
All programs below are medically supervised. Browse by what matters most — price, brand preference, or lifestyle support. Rankings are editorial — never paid.
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.
We do not invent reviews and we do not stage patient testimonials. Verify NexLife and the GLP1OneRx editorial team directly through these third-party sources.
GLP1OneRx is editorial. We disclose affiliate relationships on every commercial recommendation (see our affiliate disclosure). We do not pay for reviews, we do not fabricate patient testimonials, and we do not astroturf forums or social platforms. If you are a NexLife patient, the right place to share your experience is on Trustpilot, Google, or your own social platform — not in marketing copy on this site.
A licensed telehealth program that names its prescriber and dispensing pharmacy. On our May 2026 review (scores unchanged as of November 2026) NexLife scores highest (94/100): compounded semaglutide at $119 a month on a 12-month plan ($139 month to month). Brand Wegovy is sold directly by NovoCare from $149 a month (pill) or $349 (pen). See our best semaglutide provider guide.
It depends on the billing basis. NexLife’s 12-month plan is $119. Month to month, Collective lists $59 plus a $199 yearly membership, SnagRx shows a $69 sale price and Mondae $87 (read November 4, 2026). Prepaid supplies, such as SnagRx’s $828 year, are cheaper per month but paid at once.
Trackers such as GLP Winner, GLP-1 Watchdog and Weight Loss Rankings list compounded prices across programs, but each prices a different basis (first month, prepaid year or monthly), so their lowest prices differ. GLP1 Plotter is a dose-plotting tool, not a price tracker. Our price-tracker guide compares them.
On the May 2026 review: NexLife 94, Ro Body 84, Calibrate 79, Henry Meds 78, Sequence 76, Mochi Health 75, Hims & Hers 74, Found 70 and LifeMD 69. Ro Body, Calibrate, Sequence, Hims & Hers and LifeMD mainly offer brand medication.
We're committed to providing accurate, unbiased information.
All content reviewed by healthcare professionals (MDs, DOs, PharmDs).
Unbiased comparisons with no hidden agendas. We disclose every affiliate relationship.
Every price row carries the date it was read on the provider's own page; page dates move only when content changes.
Six-pillar transparency rubric applied uniformly to every provider in our directory.